Literature DB >> 12045262

p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.

Andreas Sturm1, Jugoh Itoh, James W Jacobberger, Claudio Fiocchi.   

Abstract

To mount an effective immune response, T cells must divide in response to antigen contact. To maintain tolerance, mucosal lamina propria T cells (LPTs) may adapt their cycling to an antigen-rich gut stimulatory environment. Here, we compared the cell cycle kinetics of LPTs and peripheral blood T cells (PBTs) before and after CD3- and CD2-mediated activation. While CD3-activated naive (CD45RA(+)) and memory (CD45RO(+)) PBTs peaked in the S and G2/M phase at 2-3 days, CD3-activated LPTs peaked at 4-6 days. In contrast, CD2 activation induced modest PBT but vigorous LPT cycling. The doubling time of CD3-activated PBTs was 1 day, while that of CD3- or CD2-activated LPTs was 2 days. LPTs failed to upregulate cyclin-dependent kinase 4 and cyclin D3, but Rb phosphorylation and cyclin A and B1 upregulation were induced by CD2 engagement. The extents of clonal expansion in LPT and PBT were comparable, indicating that LPTs' slow replication delays but does not hinder cell division. CD2-activated LPTs displayed a striking upregulation of p53, whose blockade by antisense oligonucleotides accelerated their S phase transit time to that of CD3-activated PBTs. By slowing LPT cycling, p53 may act as a negative regulator of mucosal immunity, promoting immunological tolerance by preventing excessive T cell replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045262      PMCID: PMC150997          DOI: 10.1172/JCI14967

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches.

Authors:  T W Spahn; A Fontana; A M Faria; A J Slavin; H P Eugster; X Zhang; P A Koni; N H Ruddle; R A Flavell; P D Rennert; H L Weiner
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

2.  T cell development: some cells get all the breaks.

Authors:  D R Green; M Schuler
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

3.  Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway.

Authors:  A F Buckley; C T Kuo; J M Leiden
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 4.  Cell-cycle regulation in immunity, tolerance and autoimmunity.

Authors:  D Balomenos; C Martínez-A
Journal:  Immunol Today       Date:  2000-11

5.  Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.

Authors:  J Itoh; C de La Motte; S A Strong; A D Levine; C Fiocchi
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

6.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

7.  Assessment of mitochondrial polarization status in living cells based on analysis of the spatial heterogeneity of rhodamine 123 fluorescence staining.

Authors:  E C Toescu; A Verkhratsky
Journal:  Pflugers Arch       Date:  2000-10       Impact factor: 3.657

8.  T cell effector function and anergy avoidance are quantitatively linked to cell division.

Authors:  A D Wells; M C Walsh; D Sankaran; L A Turka
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.

Authors:  R A White; M L Meistrich; A Pollack; N H Terry
Journal:  Cytometry       Date:  2000-09-01

10.  Simultaneous detection of mitochondrial respiratory chain activity and reactive oxygen in digitonin-permeabilized cells using flow cytometry.

Authors:  N A Pham; B H Robinson; D W Hedley
Journal:  Cytometry       Date:  2000-12-01
View more
  14 in total

1.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.

Authors:  A Sturm; A Z A Leite; S Danese; K A Krivacic; G A West; S Mohr; J W Jacobberger; C Fiocchi
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 2.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

Review 3.  Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.

Authors:  J Mudter; M F Neurath
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

4.  Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro.

Authors:  Claudia Guzy; Anja Schirbel; Daniela Paclik; Bertram Wiedenmann; Axel Dignass; Andreas Sturm
Journal:  Eur J Nutr       Date:  2008-11-08       Impact factor: 5.614

5.  Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.

Authors:  Miquel Sans; Silvio Danese; Carol de la Motte; Heitor S P de Souza; Brenda M Rivera-Reyes; Gail A West; Manijeh Phillips; Jeffry A Katz; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2006-10-12       Impact factor: 22.682

6.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.

Authors:  S Danese; J A Katz; S Saibeni; A Papa; A Gasbarrini; M Vecchi; C Fiocchi
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

8.  Functions of p21 and p27 in the regenerating epithelial linings of the mouse small and large intestine.

Authors:  Yu Zheng; Wenjun Bie; Ruyan Yang; Ansu O Perekatt; Aleksandra J Poole; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2008-03-07       Impact factor: 4.742

9.  Up-regulation of the phosphoinositide 3-kinase pathway in human lamina propria T lymphocytes.

Authors:  J Braunstein; F Autschbach; T Giese; F Lasitschka; A Heidtmann; B Sido; B Funke; C Reiser; A J Schröder; G Nebl; Y Samstag; S C Meuer
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

10.  TGF-β conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA.

Authors:  L M Das; M D L A Torres-Castillo; T Gill; A D Levine
Journal:  Mucosal Immunol       Date:  2012-07-11       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.